ALLO (Allogene Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku

Lambang korporat lan logo Allogene Corp (ALLO)

Following an internal restructuring, Allogene Therapeutics (ALLO) has focused on developing its own CAR-T programs. Measurable YoY EPS growth demonstrates profit dynamics, where 30.90 reflects the latest value of the metric. The company's prospects depend on the success of the ALPHA platform and the reduction of production costs, although the technological complexity of cell creation and the risk of side effects pose serious challenges for the business.

ALLO: Wutah bathi saben saham ing taun lumaku Allogene Therapeutics, Inc. 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar allogene.com (ALLO)

- rega lan prakiraan konsensus rega:
Kutipan saham Allogene Therapeutics Inc|ALLO - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Allogene Therapeutics|ALLO - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Allogene|ALLO - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku allogene.com|ALLO - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Allogene Therapeutics|ALLO - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Allogene|ALLO - Gunggung utang perusahaan|Utang-utang marang nilai buku Allogene Therapeutics|ALLO - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Allogene|Likuiditas darurat allogene.com
- informasi bathi lan kelipatan valuasi:
ALLO - Penghasilan resik|Penghasilan resik sing dikarepake Allogene Therapeutics|ALLO - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Allogene Therapeutics|ALLO - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Allogene|ALLO - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Allogene|ALLO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan allogene.com|ALLO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Allogene Therapeutics
- data pendapatan lan penerimaan dodolan:
ALLO - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan Allogene Therapeutics|ALLO - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Allogene|ALLO - Wutah dodolan YoY (TTM)
Pambiji fundamental:ALLO Allogene Corp
Produk sing diprodhuksi Allogene Therapeutics

Allogene Therapeutics (ALLO) focuses on developing high-tech CAR-T products, where intensive R&D expenditures directly impact the bottom line. Tracking annual EPS growth allows for an assessment of earnings per share dynamics relative to the previous year, filtering out market noise and revealing the actual efficiency of capital management. Growth in this indicator confirms expanding margins, signaling to the investor that the company is transitioning from a pure-spend phase to the stage of commercial realization.

Pesaing utama

Wutah bathi resik saben saham ing taun iki Legend Biotech Inc.|SANA (Sana Biotechnology Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku autolus.com AUTL|Wutah bathi saben saham ing taun lumaku Cartesian Therapeutics, Inc. (RNAC)|Wutah bathi saben saham ing taun lumaku CLLS (Cellectis SA)|Wutah bathi saben saham ing taun lumaku Caribou Bio CRBU|Tambahing bathi saben saham ing taun lumaku TIL|GNTA: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku IPSC (centurytx.com)|JSPR: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Senti Bio SNTI|ADAP (Adaptimmune Therapeutics plc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku cero.bio CERO|Wutah bathi saben saham ing taun lumaku Alaunos (TCRT)|Achilles Therapeutics plc - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku CRGX (CARGO Therapeutics, Inc)|Poseida (PSTX) - Kacepetan wutah bathi saben saham ing taun lumaku|TSVT: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku GRCL (Gracell Biotechnologies)